Australia markets closed

NeuroPace, Inc. (NPCE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.91+0.37 (+5.66%)
At close: 04:00PM EDT
6.82 -0.09 (-1.30%)
After hours: 05:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
69,073
65,421
45,520
45,183
41,138
-
Cost of revenue
17,980
17,299
13,027
11,748
10,866
-
Gross profit
51,093
48,122
32,493
33,435
30,272
-
Operating expenses
Research development
21,299
20,778
21,946
18,211
15,695
-
Selling general and administrative
56,194
54,518
51,341
38,961
27,628
-
Total operating expenses
77,493
75,296
73,287
57,172
43,323
-
Operating income or loss
-26,400
-27,174
-40,794
-23,737
-13,051
-
Interest expense
8,810
8,517
7,529
7,410
11,486
-
Total other income/expenses net
553
-315
-337
-5,381
218
-
Income before tax
-31,506
-32,956
-47,082
-36,080
-24,278
-
Income from continuing operations
-31,506
-32,956
-47,082
-36,080
-24,278
-
Net income
-31,506
-32,956
-47,082
-36,080
-24,278
-
Net income available to common shareholders
-31,506
-32,956
-47,082
-36,080
-24,050
-
Basic EPS
-1.49
-
-1.91
-2.17
-1.74
-2.70
Diluted EPS
-1.49
-
-1.91
-2.17
-1.74
-2.70
Basic average shares
25,358
-
24,595
16,609
11,103
11,103
Diluted average shares
25,358
-
24,595
16,609
11,103
11,103